Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 429859
                    [Title] => Novartis bullish to maintain growth momentum in 2009
                    [Summary] => 
Despite the gloomy economic forecasts, a dominant player of the country’s multibillion pharmaceutical company Novartis, is bullish to maintain an accelerated growth momentum this year.
                    [DatePublished] => 2009-01-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Freeman Cebu Business
                    [SectionUrl] => cebu-business
                    [URL] => 
                )

        )

)

AIREEN RONQUILLO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 429859
                    [Title] => Novartis bullish to maintain growth momentum in 2009
                    [Summary] => 
Despite the gloomy economic forecasts, a dominant player of the country’s multibillion pharmaceutical company Novartis, is bullish to maintain an accelerated growth momentum this year.
                    [DatePublished] => 2009-01-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Freeman Cebu Business
                    [SectionUrl] => cebu-business
                    [URL] => 
                )

        )

)

abtest

Novartis bullish to maintain growth momentum in 2009

January 9, 2009 - 12:00am

Despite the gloomy economic forecasts, a dominant player of the country’s multibillion pharmaceutical company Novartis, is bullish to maintain an accelerated growth momentum this year.

Freeman Cebu Business